Evergreen Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27,208
Closed -$2.37M 54
2025
Q2
$2.37M Buy
27,208
+306
+1% +$25.9K 1.33% 27
2025
Q1
$2.42M Buy
26,902
+37
+0.1% +$3.31K 1.44% 25
2024
Q4
$2.15M Buy
26,865
+663
+3% +$57.4K 1.27% 28
2024
Q3
$2.36M Buy
26,202
+7,037
+37% +$592K 1.42% 26
2024
Q2
$1.51M Hold
19,165
1% 34
2024
Q1
$1.67M Hold
19,165
1.13% 31
2023
Q4
$1.58M Buy
19,165
+510
+3% +$38.9K 1.16% 31
2023
Q3
$1.46M Buy
18,655
+278
+2% +$23.3K 1.16% 33
2023
Q2
$1.62M Buy
18,377
+1,898
+12% +$163K 1.27% 27
2023
Q1
$1.33M Buy
16,479
+2,106
+15% +$172K 1.18% 34
2022
Q4
$1.12M Buy
+14,373
New +$1.16M 1.03% 36

Other funds holding MDT

Evergreen Wealth Management's MDT Position: Q3 2025 in Review

Evergreen Wealth Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 27,208 shares — an estimated $2.37M sold.

Evergreen Wealth Management first reported a position in MDT in Q4 2022 and held it in 11 quarters. The position peaked at $2.42M in Q1 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Evergreen Wealth Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Evergreen Wealth Management sold 27,208 Medtronic shares in Q3 2025, an estimated $2.37M.
  • Evergreen Wealth Management first reported a position in Medtronic in Q4 2022 and held it in 11 quarters.
  • Evergreen Wealth Management's Medtronic position peaked at $2.42M in Q1 2025.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Evergreen Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.